The average U.S. family health insurance plan provided by an employer reached $28,303 this year, marking a 5% increase from 2025. According to an annual survey released by the health policy nonprofit KFF, workers are contributing $7,471 toward that cost, leaving nearly 157 million Americans under 65 relying on employer-sponsored coverage.
In Plain English: The Clinical Takeaway
- Premium Share Shifts: More than 40% of employers increased the share of the premium paid by workers, shifting financial strain onto household budgets.
- Specialty Drug Pressures: Rising expenditures on inpatient hospital care and brand-name metabolic medications are driving up baseline operational costs for employers.
- Access Restrictions: Major coverage providers are imposing stricter clinical validation steps—such as mandatory lifestyle plans or physician consultations—before authorizing treatments like GLP-1 receptor agonists.
Escalating Costs Outpace Household Wage Growth
The annual survey conducted by KFF, published in late October, shows that employer-sponsored health coverage costs are climbing faster than general economic indicators. While average national wages rose 3.7% over the past year, the average employee contribution for a family health plan jumped 9%. James Gelfand, president and CEO of the ERISA Industry Committee, noted that the healthcare sector continues to consume a larger fraction of every take-home dollar.
Our 2026 benchmark employer health benefits survey finds that total annual premiums for family coverage — including the employers’ share — now average $28,303, up 5% or $1,310 from 2025.Workers now contribute an average of $7,471 annually to the cost of family coverage:… pic.twitter.com/Fm6gJGSICK
Workers at smaller firms bear a notably heavier financial burden than those at larger corporations. Employees at companies with fewer than 200 workers paid an average of $9,687 toward their family insurance plans. In contrast, workers at larger companies with at least 200 employees paid $2,847 less for comparable coverage.
Specialty Pharmaceuticals and Hospital Utilization Drive Up Expenses
While steady increases in inpatient hospital care represent the largest component driving up overall premium costs, employers continue to absorb unexpected expenditures for popular diabetes and weight-loss drugs. These glucagon-like peptide-1 receptor agonists—such as Novo Nordisk’s Wegovy and Eli Lilly’s Foundayo—have created significant cost pressures for employers covering popular diabetes and weight-loss drugs.
Coverage policies for these specialized metabolic treatments are shifting rapidly. Data from the KFF survey indicates that only 33% of large employers with 5,000 or more workers covered GLP-1 medications for obesity this year, down from 43% the previous year. To manage these costs, most large organizations now require patients to undergo formal clinical evaluations or establish structured lifestyle modification plans prior to approval.
Corporate Strategies and Uncertainty Ahead
As nearly 157 million working-age Americans navigate open enrollment selections for the upcoming year, employers are exploring alternative cost-containment measures. Matthew Rae, associate director of the health care marketplace program at KFF, reported that private-sector benefits consultants project employer benefit cost increases could approach double-digit rates in 2027.
To avoid forcing workers to absorb larger premium hikes, some companies are evaluating alternative prescription services, generic drug vendors like Mark Cuban Cost Plus, SingleCare, or GoodRx, and subscription-based care options. Meanwhile, firms continue expanding access to behavioral health and substance use disorder services by incorporating virtual care providers and specialized in-person facilities into their plans.
References
- KFF. Annual Employer Health Benefits Survey. Published October 2026.
- USA Today. Here’s why a family health insurance plan costs more than $28,000. Published October 22, 2026.
